e-Drug3D 578 |
CARTEOLOL
|
cas 51781-06-7 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL OPHTHALMIC |
PK parameters Solubility SOLUBLE IN WATER |
Target TARGET BETA-1 ADRENERGIC RECEPTOR |
DrugCentral Beta-1 adrenergic receptor UNIPROT P08588 ADRB1 Beta-2 adrenergic receptor UNIPROT P07550 ADRB2 |
Download SDF file | 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one Formula: Calculated chemical properties: MW 292.37 NB_atoms 21 XLogP 1.70 PSA 75.215 NB_HD 3 NB_HA 5 fsp3 0.56 Lipinski(0=no;1=yes) 1 |
FDA NDA 019204 (pdf not found) INN (CARTEOLOL HYDROCHLORIDE) CARTROL (ABBVIE) APPROVAL= AP YEAR= 1988 NEWMOLECULARENTITY DISCONTINUED NDA 019972 (pdf not found) INN (CARTEOLOL HYDROCHLORIDE) OCUPRESS (NOVARTIS) APPROVAL= AP YEAR= 1990 DISCONTINUED NDA 075476 (pdf not found) INN (CARTEOLOL HYDROCHLORIDE) CARTEOLOL HYDROCHLORIDE (SANDOZ) APPROVAL= AP YEAR= 2000 NDA 075546 (pdf not found) INN (CARTEOLOL HYDROCHLORIDE) CARTEOLOL HYDROCHLORIDE (BAUSCH AND LOMB) APPROVAL= AP YEAR= 2000 DISCONTINUED NDA 076097 (pdf not found) INN (CARTEOLOL HYDROCHLORIDE) CARTEOLOL HYDROCHLORIDE (APOTEX INC) APPROVAL= AP YEAR= 2002 DISCONTINUED |
Other links: |